Allervax Ragweed vaccine - ImmuLogic

Drug Profile

Allervax Ragweed vaccine - ImmuLogic

Alternative Names: RagVax

Latest Information Update: 05 Jan 2000

Price : $50

At a glance

  • Originator ImmuLogic Pharmaceutical
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Discontinued Hypersensitivity

Most Recent Events

  • 05 Jan 2000 Discontinued-III for Allergy in USA (Unknown route)
  • 05 Jan 2000 Discontinued-Clinical for Allergy in Canada (Unknown route)
  • 01 Dec 1997 Investigation in Allergy in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top